Synthesis and characterisation of the N-terminal acetylated 17 to 23 fragment of thymosin beta-4 identified in TB-500
Bacteriostatic Water ( PRODUCT INTENDED FOR RESEARCH PURPOSES All of the above-mentioned properties have been observed in laboratory tests not conducted on humans, they are for informational purposes only All information contained in the descriptions is not approved by GIS, GIF or EFSA The substance is not a medicine, food product or dietary supplement, it is not suitable for human consumption The product is classified as a chemical reagent / reference material permitted for marketing in the EU, it can only be used for scientific research
The legal and ethical considerations surrounding research peptide use outside of formal research settings create additional complexities for potential users and healthcare providers
It can take fewer drinks for females or anyone with less body mass to reach this level
These peptides work by binding to growth hormone secretagogue receptors, stimulating the natural release of growth hormone from the pituitary gland
Dermal Healing Acceleration Pre-Clinical Models & Phase 2 Trials (PubMed, 2012) A review of Thymosin Beta-4s pre-clinical and clinical dermal healing evidence published on PubMed confirmed that TB4 accelerated dermal healing of full-thickness punch wounds across a wide range of animal models including normal rats and mice, steroid-treated rats, diabetic mice, and aged mice